Appendiceal neoplasms with peritoneal dissemination: outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy

Annals of Surgical Oncology
John H StewartEdward A Levine

Abstract

Appendiceal neoplasms frequently present with peritoneal dissemination (PD) and have a clinical course marked by bowel obstruction and subsequent death. Few data have correlated outcome with appendiceal histology after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IPHC). We have reviewed our experience with cytoreductive surgery and IPHC for PD from the appendix. A total of 110 cases of PD from proven appendiceal neoplasms treated with IPHC were identified from a prospectively managed database. Tumor samples were classified on pathologic review as disseminated peritoneal adenomucinosis (n = 55), peritoneal mucinous carcinomatosis (PMCA) with intermediate features (n = 18), PMCA (n = 29), or high-grade nonmucinous lesions (n = 8). A retrospective review was performed with long-term survival as the primary outcome measure. A total of 116 IPHCs were performed on 110 patients for appendiceal PD between 1993 and 2004. The 1-, 3-, and 5-year survival rates for all cases were 79.9% +/- 4.1%, 59.0% +/- 5.7%, and 53.4% +/- 6.5%, respectively. When stratified by histology, disseminated peritoneal adenomucinosis and intermediate tumors had better 3-year survival rates (77% +/- 7% and 81% +/- 10%) than PMCA and high-...Continue Reading

References

Feb 1, 1992·International Journal of Radiation Biology·E Dikomey, J Franzke
Jan 1, 1992·Journal of Cancer Research and Clinical Oncology·M Markman, D Kelsen
Nov 1, 1986·Journal of Pharmaceutical Sciences·R L Dedrick
Aug 1, 1994·The Journal of Pharmacy and Pharmacology·T KuzuyaT Nabeshima
Apr 2, 1997·Journal of the National Cancer Institute·R L Dedrick, M F Flessner
Aug 15, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M MarkmanS C Rubin
Oct 22, 1998·The British Journal of Surgery·F L Hinson, N S Ambrose
Jan 8, 1999·Cell Stress & Chaperones·J L Roti RotiM Xu
May 4, 1999·Cancer Investigation·E A MarcusN J Petrelli
Jan 6, 2000·Annals of Surgical Oncology·P H Sugarbaker, D Chang
Mar 10, 2001·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·R P McQuellonT D Rambo
Apr 18, 2002·AJR. American Journal of Roentgenology·Perry J PickhardtAmir I Kende
Sep 27, 2003·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·S van RuthF A N Zoetmulder
Mar 30, 2004·Journal of Surgical Oncology·Faheez MohamedPaul H Sugarbaker

❮ Previous
Next ❯

Citations

Oct 24, 2009·Medical Oncology·Sachin GuptaBassel F El-Rayes
Jun 10, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C H LieuM J Overman
Jun 8, 2010·World Journal of Surgical Oncology·Athanasios PetrouEvaggelos Felekouras
May 29, 2009·Annals of Surgical Oncology·Laura A LambertPaul F Mansfield
Sep 4, 2012·Annals of Surgical Oncology·Patrick L WagnerHaroon A Choudry
May 28, 2014·Journal of Oncology·Horacio N López-BasaveAbelardo Meneses Garcia
Sep 18, 2016·Annals of Surgical Oncology·Rebecca M DodsonEdward A Levine
Feb 22, 2017·World Journal of Surgical Oncology·Melissa L AbelDan G Blazer
Oct 30, 2013·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Osama M Al-Quteimat, Mariam A Al-Badaineh
Mar 29, 2018·Drug Delivery·Milad ShamsiAmir Sanati-Nezhad
Aug 14, 2015·American Journal of Clinical Oncology·Walid L ShaibBassel F El-Rayes
Nov 6, 2008·Expert Review of Anticancer Therapy·John H StewartEdward A Levine
Aug 29, 2014·Journal of Surgical Oncology·Shuja AhmedEdward A Levine
Aug 22, 2007·Annals of Surgical Oncology·Edward A Levine
Jul 1, 2010·International Journal of Experimental Pathology·Arun A MavanurJon M Davison
Nov 21, 2008·Postgraduate Medicine·Deepthi SubramanyaMichael Styler
Feb 4, 2012·Annals of Surgical Oncology·Frances AustinHaroon A Choudry
Jun 24, 2015·Annals of Surgical Oncology·Véronique KemmelCécile Brigand
Mar 5, 2013·Annals of Surgical Oncology·Patrick L WagnerHaroon A Choudry
Nov 20, 2013·Langenbeck's Archives of Surgery·Yakup KuluAlexis Ulrich
Oct 23, 2015·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·P BarriosE Aranda
Jul 1, 2017·The Oncologist·Walid L ShaibBassel F El-Rayes

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of the American College of Surgeons
Edward A LevineKonstantinos Votanopoulos
American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
David C GammonGiles F Whalen
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Richard P McQuellonT D Rambo
© 2021 Meta ULC. All rights reserved